Ambipar Emergency Response files Form 25 to delist from NYSE

Ambipar Emergency Response filed a Form 25 to remove its securities from listing and/or registration on NYSE American LLC.

Rhea-AI Filing Summary

Ambipar Emergency Response filed a Form 25 to remove its securities from listing and/or registration on NYSE American LLC. The action covers Class A Ordinary Shares and warrants, with each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share.

The exchange certified compliance with its rules and applicable regulations for striking the class of securities, and the issuer certified compliance with exchange rules and 17 CFR 240.12d2-2(c) for voluntary withdrawal.

Positive

• None.

Negative

• Delisting notice: NYSE American filed Form 25 to remove AMBI Class A Ordinary Shares and warrants from listing and/or registration.

Insights

Equity markets & listings analyst

Form 25 initiates removal of AMBI shares/warrants from NYSE American.

NYSE American filed a Form 25 covering Ambipar Emergency Response Class A Ordinary Shares and related warrants. The filing states the exchange complied with its rules to strike the class from listing and/or withdraw registration, and that the issuer complied with the exchange’s rules and 17 CFR 240.12d2-2(c) for voluntary withdrawal.

This action affects the venue where these securities are listed; the filing specifies the warrants are exercisable at $11.50 per share. The document is a procedural notice and does not detail reasons or next trading venue. Subsequent disclosures may address post-delisting trading arrangements, if any.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did AMBI (Ambipar Emergency Response) file?

A Form 25 notifying removal from listing and/or registration under Section 12(b) of the Exchange Act.

Which exchange is involved in AMBI’s Form 25?

NYSE American LLC is the exchange listed in the filing.

Which AMBI securities are affected by the Form 25?

Class A Ordinary Shares and warrants to purchase Class A ordinary shares are covered.

What is the AMBI warrant exercise price?

Each whole warrant is exercisable for one Class A ordinary share at $11.50 per share.

Does the filing state compliance with applicable rules?

Yes. It states the exchange complied with its rules and cites 17 CFR 240.12d2-2; the issuer complied with 17 CFR 240.12d2-2(c).

Who signed the Form 25 notice and when?

Signed by Tyler Mastronardi, Analyst, Market Watch, dated 2025-10-29.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/29/2025 - 09:56 AM Learn about SEC filing dates

UNITED STATES

OMB APPROVAL

OMB Number:			3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:			1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

001-41638

Issuer:	Ambipar Emergency Response
Exchange:	NYSE AMERICAN LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	Avenida Angelica 2346 5th Floor
	Sao Paulo		01228-200
Telephone number:					+55 (11) 3526-3526

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

Class A Ordinary Shares; Warrants to purchase Class A ordinary shares, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements fo the Securities Exchange Act of 1934, NYSE AMERICAN LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

2025-10-29	By	Tyler Mastronardi		Analyst, Market Watch
Date		Name		Title

¹ Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.